Avoiding bad science through better research design
Health policies and treatments should be based on solid evidence. But what if such evidence is flawed, and the resulting treatments and policies are therefore… Read more »
Stephen B. Soumerai is Professor of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute and Director of the Drug Policy Research Group, a research program focused on pharmaceutical outcomes and quality of health care. He is co-chair of the Evaluative Sciences and Statistics Concentration within Harvard University’s health policy Ph.D. program.
Dr. Soumerai has published more than 250 original scientific articles and is well known nationally and internationally for his work on the impact of health policies and methods to improve the quality of medical practice. He frequently advises Congress and state legislatures on the design of cost containment, insurance coverage and quality-of-care policies. His research has been used extensively in policy decisions by Medicaid and Medicare.
Dr. Soumerai has published more than 250 original scientific articles and is well known nationally and internationally for his work on the impact of health policies and methods to improve the quality of medical practice. He frequently advises Congress and state legislatures on the design of cost containment, insurance coverage and quality-of-care policies. His research has been used extensively in policy decisions by Medicaid and Medicare.
Latest posts by Stephen Soumerai, ScD (see all)
- Avoiding bad science through better research design - 10th September 2015